The ascendancy of Viagra and its influence on the drug landscape presents a intricate question for investors. While the first sales statistics were impressive, the exclusivity has lapsed, leading to a wave of off-brand alternatives that are chipping away at revenue. Furthermore, the sector is facing issues related to demographic trends and evolv… Read More